Mid Cap Stocks To Research – February 15th

Hims & Hers Health, SoundHound AI, Nebius Group, Direxion Daily TSLA Bull 2X Shares, and Recursion Pharmaceuticals are the five Mid Cap stocks to watch today, according to MarketBeat’s stock screener tool. Mid cap stocks refer to companies with a market capitalization typically ranging between $2 billion and $10 billion. These stocks are considered to be in the middle range in terms of size and are often perceived as possessing a balance of growth potential and stability compared to small cap and large cap stocks. These companies had the highest dollar trading volume of any Mid Cap stocks within the last several days.

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

HIMS stock traded up $1.23 during midday trading on Friday, hitting $60.41. 38,691,338 shares of the company traded hands, compared to its average volume of 11,475,684. Hims & Hers Health has a twelve month low of $9.22 and a twelve month high of $64.84. The business has a 50 day simple moving average of $32.06 and a 200-day simple moving average of $24.26. The stock has a market capitalization of $13.20 billion, a price-to-earnings ratio of 137.31 and a beta of 1.35.

SoundHound AI (SOUN)

SoundHound AI, Inc. develops independent voice artificial intelligence (AI) solutions that enables businesses across automotive, TV, and IoT, and to customer service industries to deliver high-quality conversational experiences to their customers. Its products include Houndify platform that offers a suite of Houndify tools to help brands build conversational voice assistants, such as Application Programming Interfaces (API) for text and voice queries, support for custom commands, extensive library of content domains, inclusive software development kit platforms, collaboration capabilities, diagnostic tools, and built-in analytics; SoundHound Chat AI that integrates with knowledge domains, pulling real-time data like weather, sports, stocks, flight status, and restaurants; and SoundHound Smart Answering is built to offer customer establishments custom AI-powered voice assistant.

SOUN stock traded down $4.28 during midday trading on Friday, hitting $10.97. 176,466,981 shares of the company traded hands, compared to its average volume of 51,269,032. The business has a 50 day simple moving average of $16.62 and a 200-day simple moving average of $9.50. The stock has a market capitalization of $4.31 billion, a price-to-earnings ratio of -30.47 and a beta of 2.56. The company has a quick ratio of 2.58, a current ratio of 2.58 and a debt-to-equity ratio of 0.13. SoundHound AI has a twelve month low of $3.11 and a twelve month high of $24.98.

Nebius Group (NBIS)

Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company’s services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability.

Shares of Nebius Group stock traded up $2.79 during midday trading on Friday, hitting $44.49. The company had a trading volume of 34,999,875 shares, compared to its average volume of 11,253,757. The company has a market cap of $10.48 billion, a PE ratio of -78.05 and a beta of 2.57. Nebius Group has a 1-year low of $14.09 and a 1-year high of $47.68. The company’s 50 day moving average price is $33.11.

Direxion Daily TSLA Bull 2X Shares (TSLL)

TSLL stock traded down $0.04 during midday trading on Friday, hitting $20.23. The stock had a trading volume of 75,670,548 shares, compared to its average volume of 69,088,945. The firm has a market capitalization of $3.91 billion, a price-to-earnings ratio of 40.38 and a beta of -5.14. Direxion Daily TSLA Bull 2X Shares has a 52 week low of $4.94 and a 52 week high of $41.50. The stock has a 50-day simple moving average of $27.96 and a 200 day simple moving average of $18.20.

Recursion Pharmaceuticals (RXRX)

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers.

RXRX stock traded up $2.03 during midday trading on Friday, hitting $10.53. The stock had a trading volume of 82,298,499 shares, compared to its average volume of 18,530,172. The firm has a market capitalization of $4.11 billion, a price-to-earnings ratio of -6.88 and a beta of 0.86. The stock has a 50-day simple moving average of $7.27 and a 200 day simple moving average of $6.92. Recursion Pharmaceuticals has a 52 week low of $5.60 and a 52 week high of $15.74. The company has a current ratio of 4.35, a quick ratio of 4.35 and a debt-to-equity ratio of 0.04.